Study of Radiation Treatment Effects and Outcomes in Women With Uterine Cancers at SantOrsola Polyclinic

What this Trial Is About

Researchers are collecting data on radiation treatment for uterine neoplasms, including endometrial and cervical cancers. The study aims to understand how tumor response and possible side effects relate to radiation doses, treatment techniques, and combinations with other therapies. By analyzing patient and disease characteristics, the study seeks to identify patterns that may help predict and prevent radiation-related toxicities in the future. This observational study gathers information from patients treated at the Radiotherapy Unit of the SantOrsola Polyclinic, including those diagnosed and treated since January 1, 2000. The data covers various treatment settings, dosages, fractionation schedules, and techniques used in radiotherapy, alone or combined with other therapies. Both retrospective and prospective data collection phases are included, covering treatments up to December 15, 2030. Participants provide information on tumor response, local disease recurrence, and survival during follow-up visits up to 12 months after treatment. Researchers also monitor acute and late toxicities, retreatments, and overall patient outcomes. The study involves around 5000 patients, without direct intervention or risk to participants, focusing solely on data collection to improve future care for uterine neoplasms.

Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms